Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

347
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
347
Testing a Claim about Standard Deviation01:19

Testing a Claim about Standard Deviation

2.8K
A complete procedure to test a claim about population standard deviation or population variance is explained here.
The hypothesis testing for the claim of population standard deviation (or variance) requires the data and samples to be random and unbiased. The population distribution also must be normal. There is no specific requirement on the sample size as the estimation is based on the chi-square distribution.
As a first step, the hypothesis (null and alternative) concerning the claim about...
2.8K
Testing a Claim about Population Proportion01:24

Testing a Claim about Population Proportion

3.8K
A complete procedure for testing a claim about a population proportion is provided here.
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
3.8K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

505
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
505
Study Design in Statistics01:15

Study Design in Statistics

9.9K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
9.9K
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

331
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
331

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emulating Comparative Oncology Trials With Real-World Evidence Studies (ENCORE): Process Development and Methodological Considerations for Oncology Real-World Data.

Clinical pharmacology and therapeutics·2026
Same author

Potential for extreme bias due to outcome misclassification in relative measures of effect for rare time-to-event outcomes.

American journal of epidemiology·2025
Same author

A Benchmark, Expand, and Calibration (BenchExCal) Trial Emulation Approach for Using Real-World Evidence to Support Indication Expansions: Design and Process for a Planned Empirical Evaluation.

Clinical pharmacology and therapeutics·2025
Same author

Implementing Accuracy, Completeness, and Traceability for Data Reliability.

JAMA network open·2025
Same author

Evaluation of Drug-Drug Interactions in Pharmacoepidemiologic Research.

Pharmacoepidemiology and drug safety·2025
Same author

Comparative risk of opioid overdose in patients who initiated antibiotics for urinary tract infection while on long-term opioid therapy.

American journal of epidemiology·2024

Related Experiment Video

Updated: Dec 30, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

Improving measurement of binary covariates in claims data: A simulation study.

John G Connolly1, Robert J Glynn1, Sebastian Schneeweiss1

  • 1Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Harvard University, Boston, Massachusetts.

Pharmacoepidemiology and Drug Safety
|January 24, 2020
PubMed
Summary

When using claims-based definitions for confounders, a new "two-algorithm indicator" approach may offer more unbiased estimates than using sensitive or specific definitions alone. This method improves adjustment for confounders in health research.

Keywords:
administrative claims dataconfounder misclassificationconfoundingpharmacoepidemiologysimulation

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

Related Experiment Videos

Last Updated: Dec 30, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

Area of Science:

  • Health Informatics
  • Biostatistics
  • Epidemiology

Background:

  • Claims-based definitions for binary confounders present challenges in epidemiological studies.
  • Choosing between sensitive or specific definitions can impact analysis outcomes.
  • Novel methods are needed to effectively adjust for confounders using multiple definitions.

Purpose of the Study:

  • To compare the effectiveness of adjusting for sensitive or specific confounder definitions individually.
  • To evaluate two novel approaches: a "two-algorithm indicator" and a "two-algorithm restriction" method.
  • To determine the optimal strategy for handling binary confounders with multiple claims-based definitions.

Main Methods:

  • Simulated patient data with binary exposure, outcome, and confounder.
  • Created nested, misclassified confounder versions using validated heart failure definitions.
  • Compared adjustment methods: sensitive definition, specific definition, two-algorithm indicator, and two-algorithm restriction.

Main Results:

  • Crude odds ratio (OR) was 1.33.
  • Adjusting for specific/sensitive definitions yielded ORs of 1.09/1.14.
  • The two-algorithm indicator approach resulted in an OR of 1.07.
  • The two-algorithm restriction approach yielded an OR of 1.02 but excluded 20% of the cohort.

Conclusions:

  • The "two-algorithm indicator" approach may provide a less biased point estimate compared to using either definition alone.
  • This novel method offers a potential improvement for adjusting claims-based confounders.
  • The "two-algorithm restriction" approach may lead to significant cohort exclusion.